Last reviewed · How we verify

NCT05330091

Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study

Status unknown Last updated 3 August 2022
What this trial tests

trial testing Once Daily Women's Probiotic in Vaginal Health in 200 participants. Status unknown.

Timeline
9 February 2022
Primary endpoint
30 September 2022
31 October 2022

Quick facts

Lead sponsorGarden of Life, LLC
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date9 February 2022
Primary completion30 September 2022
Estimated completion31 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Garden of Life, LLC

Who can join

Adults 19 to 70, female only, with Vaginal Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This decentralized observational study is designed to understand the effects of daily consumption of once daily woman's probiotic (ODWP) on vaginal pH levels in healthy female populations ages 19-70 years of age across the United States.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vaginal Health

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05330091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing